143 related articles for article (PubMed ID: 34408351)
1. Cervical Cancer Screening in HIV-Positive Women in India: Why, When and How?
Boddu A; Bhatla N; Vashist S; Mathur S; Mahey R; Natarajan J; Malik R; Vanamail P; Rai S; Kumari A; Dar L; Wig N
J Obstet Gynaecol India; 2021 Jun; 71(3):304-312. PubMed ID: 34408351
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
3. Anal dysplasia screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
[TBL] [Abstract][Full Text] [Related]
4. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
5. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.
Chung MH; McKenzie KP; De Vuyst H; Richardson BA; Rana F; Pamnani R; Njoroge JW; Nyongesa-Malava E; Sakr SR; John-Stewart GC; Mugo NR
AIDS; 2013 Nov; 27(18):2909-19. PubMed ID: 23842133
[TBL] [Abstract][Full Text] [Related]
6. Screening of cervical neoplasia in HIV-infected women in India.
Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
[TBL] [Abstract][Full Text] [Related]
7. Primary and Triage Cervical Screening Diagnostic Value of Methods for the Detection of Cervical Dysplasia.
Njue JK; Muturi M; Kamau L; Lwembe R
Biomed Res Int; 2022; 2022():1930102. PubMed ID: 36164451
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
9. Performance of HPV testing, Pap smear and VIA in women attending cervical cancer screening in Kilimanjaro region, Northern Tanzania: a cross-sectional study nested in a cohort.
Mremi A; Mchome B; Mlay J; Schledermann D; Blaakær J; Rasch V
BMJ Open; 2022 Oct; 12(10):e064321. PubMed ID: 36316070
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
11. The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India.
Anderson JR; Yogeshkumar S; Lu E; Yenokyan G; Thaler K; Mensa M; Chikaraddi S; Lokare L; Gudadinni MR; Antartani R; Donimath K; Patil B; Bidri S; Goudar SS; Derman R; Dalal A;
BJOG; 2023 Nov; 130 Suppl 3(Suppl 3):158-167. PubMed ID: 37932903
[TBL] [Abstract][Full Text] [Related]
12. Role of p16 testing in cervical cancer screening among HIV-infected women.
McGrath CJ; Garcia R; Trinh TT; Richardson BA; John-Stewart GC; Nyongesa-Malava E; Mugo NR; Glynn EH; Sakr SR; De Vuyst H; Chung MH
PLoS One; 2017; 12(10):e0185597. PubMed ID: 29023464
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
15. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
Syrjänen K; Naud P; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Matos J; Gontijo R; Sarian L; Braganca J; Arlindo FC; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S
Anticancer Res; 2005; 25(5):3469-80. PubMed ID: 16101165
[TBL] [Abstract][Full Text] [Related]
16. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
[TBL] [Abstract][Full Text] [Related]
17. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
[TBL] [Abstract][Full Text] [Related]
18. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa.
Firnhaber C; Mayisela N; Mao L; Williams S; Swarts A; Faesen M; Levin S; Michelow P; Omar T; Hudgens MG; Williamson AL; Allan B; Lewis DA; Smith JS
PLoS One; 2013; 8(1):e53494. PubMed ID: 23326441
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India.
Gravitt PE; Paul P; Katki HA; Vendantham H; Ramakrishna G; Sudula M; Kalpana B; Ronnett BM; Vijayaraghavan K; Shah KV;
PLoS One; 2010 Oct; 5(10):e13711. PubMed ID: 21060889
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
